Token Communities, Ltd. Announces Entry into Distribution Agreement
July 25, 2023 14:04 ET | Token Communities Ltd
BRADENTON, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (Symbol: TKCM, “Token Communities” or the “Company”), today announced that the Company’s subsidiary Elements of Health and...
Research Nester Logo.jpg
Blood Glucose Monitoring System Market revenue to hit USD 46 Billion by 2033, says Research Nester
July 13, 2023 07:30 ET | Research Nester
New York, July 13, 2023 (GLOBE NEWSWIRE) -- The global blood glucose monitoring system market size is expected to expand at ~10% CAGR from 2023 to 2033. The market is anticipated to garner a revenue...
Token Communities, Ltd. Announces Launch of its First Two Naturopathic Supplements
June 16, 2023 10:16 ET | Token Communities Ltd
BRADENTON, Fla., June 16, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (“Token Communities” or the “Company”), today announced that the Company has launched the first two of its naturopathic...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Announces Two Studies Exploring the Role of ‘Inflammation Regulator’ Gelsolin in Type 2 Diabetes
April 13, 2023 14:03 ET | BioAegis Therapeutics
Gelsolin decreased microparticle-driven inflammation and mitigated activation of the NLRP3 inflammasome in type 2 diabetes. Low levels of gelsolin identified in individuals with type 2 diabetes...
Artificial Pancreas Device System (APDS) Market Worth $3.58Bn, Globally, by 2028 at 20.28% CAGR | The Insight Partners
April 05, 2023 05:52 ET | The Insight Partners
Pune, INDIA., April 05, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Artificial Pancreas Device System Market Forecast to 2028 – by Type and Geography,” the market is expected to...
French Biotech Compa
French Biotech Company AdipoPharma Secures Series A Funding for Groundbreaking Diabetes Drug
January 23, 2023 03:10 ET | AdipoPharma
Newton Biocapital II Leads Funding Round For First-of-Its-Kind Drug to Treat Insulin ResistanceFirst Breakthrough Addressing Insulin Resistance in Type 2 Diabetes TreatmentSTRASBOURG, France,...
Blood Glucose Monitoring Devices Market to reach $28.76 Billion in 2030 with a CAGR of around 7.92%
New York, United States, June 02, 2022 (GLOBE NEWSWIRE) -- Blood glucose monitoring is the utilization of a glucose meter for monitoring and identifying the overall concentration content of glucose...
GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
March 14, 2022 09:15 ET | GlucoTrack, Inc.
To begin trading under the Nasdaq Symbol GCTK Rutherford, NJ and Or Yehuda, Israel, March 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), formerly...
Cardiometabolic Diseases Market Size ($121,804.49Mn by 2028) Lead by Cardiovascular Disease (3.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 09:54 ET | The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...
Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements
August 12, 2021 09:15 ET | Integrity Applications, Inc.
Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring...